Assyro AI

Orange Book product · Generic (ANDA)

ALMOTRIPTAN MALATE

ALMOTRIPTAN MALATE

Generic (ANDA)ANDA 205171TE ABRX MYLAN

At a glance

Nov 09, 2015

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 09, 2015

    10 yr 9 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ALMOTRIPTAN MALATE

Strength

EQ 6.25MG BASE

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 205171

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ALMOTRIPTAN MALATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.